Benzodiazepine Site Pharmacokinetic/Pharmacodynamic Quantification in Man: Direct Measurement of Drug Occupancy and Effects on the Human Brain In Vivo-Reference-Cited by-同舟云学术

Benzodiazepine Site Pharmacokinetic/Pharmacodynamic Quantification in Man: Direct Measurement of Drug Occupancy and Effects on the Human Brain In Vivo

Published:1996 Issue:9-10 Volume:35 Page:1483-1491
ISSN:0028-3908
Container-title:Neuropharmacology
language:en
Short-container-title:Neuropharmacology

Author:

MALIZIA A.L,GUNN R.N,WILSON S.J,WATERS S.H,BLOOMFIELD P.M,CUNNINGHAM V.J,NUTT D.J

Publisher

Elsevier BV

Subject

Cellular and Molecular Neuroscience,Pharmacology

Reference37 articles.

1. The pharmacology of saccadic eye movements I: effects of the benzodiazepine receptor ligands midazolam and flumazenil;Ball;Psychopharmacology,1991

2. In vivo bidirectional modulatory effect of benzodiazepine receptor ligands on GABAergic transmission evaluated by positron emission tomography in non human primates;Brouillet;Brain Res.,1991

3. Electroencephalographic effects of benzodiazepines I: choosing an EEG parameter to measure the effect of midazolam on the central nervous system;Buhler;Clin. Pharmacol. Ther.,1990

4. Status epilepticus induced by pentylenetetrazole modulates in vivo [11C]Ro 15-1788 binding to benzodiazepine receptors. Effects of ligands acting at the supramolecular receptor complex;Chavoix;Eur. J. Pharmacol.,1988

5. Radioligand studies in brain: kinetic analysis of PET data;Cunningham;Med. Chem. Res.,1994

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A randomized, double-blind, placebo-controlled phase II trial to explore the effects of a GABAA-α5 NAM (basmisanil) on intellectual disability associated with Down syndrome;Journal of Neurodevelopmental Disorders;2022-02-05

2. Basmisanil, a highly selective GABAA-α5 negative allosteric modulator: preclinical pharmacology and demonstration of functional target engagement in man;Scientific Reports;2021-04-08

3. Padsevonil randomized Phase IIa trial in treatment-resistant focal epilepsy: a translational approach;Brain Communications;2020

4. GABAA receptor occupancy by subtype selective GABAAα2,3 modulators: PET studies in humans;Psychopharmacology;2016-12-24

5. Differences between magnetoencephalographic (MEG) spectral profiles of drugs acting on GABA at synaptic and extrasynaptic sites: A study in healthy volunteers;Neuropharmacology;2015-01